The accumulation of senescent cells is increasingly recognized as a hallmark of biological aging, contributing to various chronic medical conditions. In this study, researchers developed a composite SASP Score that integrates large-scale population proteomics data with a semi-supervised deep learning framework to measure the senescence-associated secretory phenotype (SASP) in blood.
The study’s methodology involved several key steps:
- Selection of biologically curated SASP proteins.
- Development of a Guided autoencoder with Transformer (GAET) model using data from the UK Biobank Pharma Proteomics Project (UKB-PPP).
- Internal evaluation and association analyses within the UK Biobank.
- External validation and longitudinal assessment in an independent randomized clinical trial cohort.
The findings indicated that the deep learning-based SASP Score was a strong, independent predictor of mortality risk and the onset of serious chronic medical conditions, including dementia, chronic obstructive pulmonary disease (COPD), myocardial infarction, and stroke. Furthermore, in an independent cohort, multimodal exercise significantly altered the SASP Score trajectory over an 18-month period.
This research highlights the potential of the SASP Score as a biomarker for systemic cellular senescence burden, offering a valuable tool for aging research and the evaluation of interventions aimed at improving health outcomes.
What this study does not show
This study does not establish direct causal relationships between the SASP Score and specific health outcomes, nor does it provide evidence of clinical utility in a real-world setting.
Evidence scorecard
- Analytic validity: established
- Clinical validity: established
- Clinical utility: partial
The evidence is based on primary research involving human subjects.